Quent Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Quent Capital's BMRN Position: Q3 2026 in Review
Quent Capital increased its BioMarin Pharmaceuticals (BMRN) stake by 20% in Q3 2026, buying an estimated $3.34K and bringing the position to 319 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.
Quent Capital first reported a position in BMRN in Q4 2021 and has held it in 19 quarters since. The position peaked at $147K in Q1 2023. 559 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Quent Capital held 319 shares of BioMarin Pharmaceuticals worth $19.1K as of Q3 2026.
- Quent Capital bought 53 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $3.34K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1099 holding.
- Quent Capital first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Quent Capital's BioMarin Pharmaceuticals position peaked at $147K in Q1 2023.
- 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.